Zileuton Alleviates Radiation-Induced Cutaneous Ulcers via Inhibition of Senescence-Associated Secretory Phenotype in Rodents

Int J Mol Sci. 2022 Jul 29;23(15):8390. doi: 10.3390/ijms23158390.

Abstract

Radiation-induced cutaneous ulcers are a challenging medical problem for patients receiving radiation therapy. The inhibition of cell senescence has been suggested as a prospective strategy to prevent radiation ulcers. However, there is no effective treatment for senescent cells in radiation ulcers. In this study, we investigated whether zileuton alleviated radiation-induced cutaneous ulcer by focusing on cell senescence. We demonstrate increased cell senescence and senescence-associated secretory phenotype (SASP) in irradiated dermal fibroblasts and skin tissue. The SASP secreted from senescent cells induces senescence in adjacent cells. In addition, 5-lipoxygenase (5-LO) expression increased in irradiated dermal fibroblasts and skin tissue, and SASP and cell senescence were regulated by 5-LO through p38 phosphorylation. Finally, the inhibition of 5-LO following treatment with zileuton inhibited SASP and mitigated radiation ulcers in animal models. Our results demonstrate that inhibition of SASP from senescent cells by zileuton can effectively mitigate radiation-induced cutaneous ulcers, indicating that inhibition of 5-LO might be a viable strategy for patients with this condition.

Keywords: 5-lipoxygenase; cutaneous radiation ulcer; p38; senescence; zileuton.

MeSH terms

  • Animals
  • Cellular Senescence
  • Fibroblasts* / metabolism
  • Hydroxyurea / analogs & derivatives
  • Phenotype
  • Rodentia
  • Senescence-Associated Secretory Phenotype
  • Ulcer* / metabolism

Substances

  • zileuton
  • Hydroxyurea